1258428-05-5
1258428-05-5
Chemical Structure
Macitentan-d4
Synonym(s): ACT-064992-d4
- CAS No.: 1258428-05-5
- Formula:C19H16D4Br2N6O4S
- Molecular Weight:592.30
InChIKey: JGCMEBMXRHSZKX-LZMSFWOYSA-N
SMILES: O=S(NCCC)(NC1=NC=NC(OC([2H])([2H])C([2H])([2H])OC2=NC=C(Br)C=N2)=C1C3=CC=C(Br)C=C3)=O
Biological Activity: Macitentan-d4 is a deuterium labeled Sulfamethoxazole. Macitentan is an orally active, non-peptide dual ETA and ETB (endothelin) receptor antagonist. Macitentan has the potential for idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Macitentan-d4 | 99.85% | Macitentan-d4 is a deuterium labeled Sulfamethoxazole. Macitentan is an orally active, non-peptide dual ETA and ETB (endothelin) receptor antagonist. Macitentan has the potential for idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Macitentan (Standard) | 99.79% | Macitentan (Standard) is the analytical standard of Macitentan. This product is intended for research and analytical applications. Macitentan (ACT-064992) is an orally active, non-peptide dual ETA and ETB (endothelin receptor) antagonist. Macitentan has the potential for idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Macitentan | 99.85% | Macitentan (ACT-064992) is an orally active, non-peptide dual ETA and ETB (endothelin receptor) antagonist. Macitentan has the potential for idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
